| Financial Year |
March 31 2023 |
| Monetary Funds |
141,580,127.84 |
| Held-for-trading Financial Assets |
228,179,497.25 |
| Notes Receivable |
-- |
| Accounts Receivable |
19,163,642.96 |
| Advances to Suppliers |
42,834,273.69 |
| Other Receivables |
15,821,561.15 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
177,095,330.90 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
105,295,451.22 |
| Total Current Assets |
729,969,885.01 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
11,540,724.95 |
| Investment Properties |
7,540,278.57 |
| Fixed Assetes |
198,149,563.55 |
| Under-construction Projects |
87,321,594.01 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
47,487,412.76 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
101,172.15 |
| Deferred Income Tax Assets |
2,263,049.01 |
| Other Non-Current Assets |
5,626,900.00 |
| Sub-Total of Non-Current Assets |
360,785,816.03 |
| Total Assets |
1,090,755,701.04 |
| Short-Term Loans |
110,113,789.97 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
37,190,662.75 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,826,376.93 |
| Taxes Payable |
10,446,619.48 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
24,323,791.80 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
354,516.02 |
| Other Current Liabilities |
1,259,662.29 |
| Sub-Total of Current Liabilities |
202,961,889.85 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,765.75 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,621,149.83 |
| Total Liabilities |
207,583,039.68 |
| Paid-In Capital(Or Share Stock) |
125,230,000.00 |
| Capital Surplus |
428,880,579.82 |
| Surplus Reserve |
61,336,095.57 |
| LESS:Treasury Stock |
19,212,600.00 |
| Undistributed Profits |
278,766,837.78 |
| Minority Stockholder's Interest |
8,171,748.19 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
875,000,913.17 |
| Owner's Equity（Stockholder's Equity） |
883,172,661.36 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,090,755,701.04 |
